Professional Documents
Culture Documents
Student Name
University
Course
Professor Name
Date
PSYCHOPHARMACOLOGY 2
Introduction
Psychopharmacology is the aspect that entails the study of the use of drugs to treat human
psychopharmacology is handled with utmost skills and therapeutic experience when treating
Summary
The article explores the aspect of mental disorders and their involvement with
cardiovascular diseases. First, it explains how depression plays a part in cardiovascular diseases.
In this case, depression is also a factor that can lead to heart failure (Piña et al., 2018). Besides,
mental disorders and cardiovascular diseases need to be administered to the patient. Also, drugs
cardiovascular diseases resulting from depression and anxiety (Carlson & Birkett, 2017).
Brief Introduction
Over the recent years, psychological disorders have played a significant role in causing
cardiovascular diseases (Carlson & Birkett, 2017). In most cases, cardiovascular diseases are the
primary cause of mortality and morbidity in the general public. In most cases, psychological
disorders result from mental instability (Carlson & Birkett, 2017). Therefore, psychological
disorders can be significantly reduced by taking into account drug and psychological therapies
Heartbeat rate which in most case lead to arrhythmias (Carlson & Birkett, 2017).
Depressed patients tend to have an abnormal main this case to counter the psychological
PSYCHOPHARMACOLOGY 3
disorders; the patients have to undergo drug therapy to counter depression, anxiety, and
Mechanism of Action
The best mechanism of action, in this case, is the use of addictive drugs. The use of drugs
causes alters the functioning of the cells that produce the hormones and enzymes that lead to
psychological problems (Carlson & Birkett, 2017). Thus, drug action is efficient in dealing with
psychological disorders.
PSYCHOPHARMACOLOGY 4
References
Carlson, N. R., & Birkett, M. (2017). Physiology of behavior (12th ed.). Boston, MA: Pearson.
Piña, I. L., Di Palo, K. E., & Ventura, H. O. (2018). Psychopharmacology and cardiovascular